1 |
Iron oxide NPs |
Myocardium from mice |
Oxidant by Nox 4 overexpression |
[6] |
2 |
WO3-Pt NPs |
Tumor cells |
Oxidant. NADPH oxidase biomimetic |
[7] |
3 |
Silver NPs |
Human umbilical vein endothelial cells |
Oxidant by increasing Nox 4 expression |
[8] |
4 |
Silver NPs |
Myocardium from rats |
Increase in hypertension due to a decrease in NO levels |
[9] |
5 |
PLGA NPs |
Hypertensive rats |
Carrier. Treatment for hypertension |
[10] |
6 |
PLGA NPs |
Human umbilical vascular endothelial cells |
ROS scavenger at the vascular level and endothelial protector |
[11] |
7 |
PLGA NPs |
Rat focal cerebral ischemia/reperfusion injury |
SOD carrier |
[12] |
8 |
PEGylated quantum dots |
AT1R-expressing cells |
Carrier of angiotensin-II |
[13] |
9 |
Silica NPs |
Human endothelial cells |
Endothelial injury induced by mitochondrial dysfunction |
[14] |
10 |
Silica NPs |
Aorta from rat |
Endothelial dysfunction induced by oxidative stress |
[15] |
11 |
PVAX |
Hindlimb and liver from an ischemia/reperfusion model in mice |
Antioxidant, anti-inflammatory, and anti-apoptotic activity |
[16] |
12 |
PLGA-β-PEG-TPP NPs |
Mitochondria-acting therapeutics |
Nanocarriers |
[17] |
13 |
RNP |
A middle cerebral artery from rats with cerebral ischemia/reperfusion injury |
Neuroprotective agent due to its ability to scavenge free radicals |
[18] |
14 |
Redox-polymer nanotherapeutics |
Brain from SAMP8 mice |
Treatment of the neurodegenerative diseases |
[19] |
15 |
Nanoceria |
PC12 neuronal-like cells |
SOD and catalase mimetic |
[20] |
16 |
Nanoceria |
Mouse hippocampal brain slice model of ischemia |
Reduction of oxidative and nitrosative damage after stroke |
[21] |
17 |
Nanoceria |
Murine macrophages |
Anti-inflammatory and NO scavenger |
[22] |
18 |
Nanoceria |
Cultured rat H9c2 cardiomyocytes |
Antioxidant |
[23] |
19 |
Nanoceria |
Murine myocardium |
Antioxidant and anti-inflammatory |
[24] |
20 |
Nanoceria |
Human aortic endothelial cells |
Inflammatory effect |
[25] |
21 |
Nanoceria |
Aorta from mice |
Vascular dysfunction |
[26] |
22 |
Nanoceria |
Arterioles from hypertensive rats |
Vascular antioxidant |
[27] |
23 |
Nanoceria |
Arteriola from rats |
Prooxidant. Microvascular dysfunction |
[28] |
24 |
Iron oxide, yttrium oxide, cerium oxide, zinc oxide |
Human vascular endothelial cell line |
Pro-inflammatory |
[29] |
25 |
NPs based on polyoxalate |
Doxorubicin-treated mice heart |
Antioxidant and anti-inflammatory |
[30] |
26 |
Polyketal particles |
Rat myocardium |
SOD carrier |
[31] |
27 |
Silver NPs |
Human pulmonary epithelial cell line 16HBE14 |
Dose and process of uptake |
[32] |
28 |
Silver NPs |
Human alveolar epithelial cells (A549) |
Spherical particles had no effect than silver wires |
[33] |
29 |
Silver NPs |
Human alveolar epithelial cells (A549) |
Cells were only sensitive to high Ag-ion concentrations |
[34] |
30 |
Silver NPs |
T84 cells (ATCC CCL-248™), a human colorectal carcinoma cell line |
Small AgNPs have significant effects on intestinal permeability |
[35] |
31 |
Silver NPs |
Porcine kidney (Pk15) cells |
AgNPs had only insignificant toxicity at concentrations lower than 25 mg/L, whereas Ag+ exhibited a significant decrease in cell viability at higher concentration |
[36] |
32 |
Silver NPs |
Human HCE-T corneal epithelial cells |
Mammalian cell toxicity was observed at high (8–12 μM silver ion) silver levels in serum-free culture |
[37] |
33 |
Silver NPs |
RAW264.7 macrophages |
Low cell pro-inflammatory cytokine activation was observed |
[37] |
34 |
Silver NPs |
Human tongue squamous carcinoma SCC-25 |
Reduced proliferation and viability |
[38] |
35 |
Silver NPs |
Alveolar epithelial cells, macrophages, and dendritic cells |
Adverse effects were also only found at high silver concentrations |
[39] |
36 |
Silver NPs |
Human microvascular endothelial cells |
Loss of membrane integrity at higher concentrations |
[40] |
37 |
Silver NPs |
Bovine retinal endothelial cells |
Enhanced apoptosis |
[41] |
38 |
Silver NPs |
Dalton’s lymphoma ascites |
Anti-tumor activity |
[42] |
39 |
Silver NPs |
HepG2 cells |
Non-cytotoxic doses induced p38 MAPK pathway activation and led to the promotion of HepG2 cell proliferation |
[43] |
40 |
Silver NPs |
HaCaT cells |
HaCaT cells were found to be resistant |
[44] |
41 |
Silver NPs |
HeLa cells |
HeLa cells were found to be more sensitive |
[44] |
42 |
Silver NPs |
Embryonic neural stem cells |
Ag-NPs-induced neurotoxicity |
[45] |
43 |
Silver NPs |
Primary mixed neural cell cultures |
Strong effects of SNP associated with calcium dysregulation and ROS formation in primary neural cells |
[46] |
44 |
Silver NPs |
Mouse brain neural cells |
AgNPs could alter gene and protein expressions of β-amyloid (Aβ) deposition |
[47] |
45 |
Silver NPs |
Human embryonic neural precursor Cell |
AgNPs exposure causes a significant stress response in the growing Human neural progenitor cells (hNPC) |
[48] |
46 |
Silver NPs |
HT22 mouse hippocampal neuronal cells |
AgNPs modulated HT22 cell cycle, proliferation, induced oxidative stress, and 53BP1 recruitment |
[49] |